Literature DB >> 33466869

Identification of Molecular Basis for Objective Discrimination of Breast Cancer Cells (MCF-7) from Normal Human Mammary Epithelial Cells by Raman Microspectroscopy and Multivariate Curve Resolution Analysis.

Keita Iwasaki1, Asuka Araki2, C Murali Krishna3, Riruke Maruyama2, Tatsuyuki Yamamoto4,5, Hemanth Noothalapati5,6.   

Abstract

Raman spectroscopy (RS), a non-invasive and label-free method, has been suggested to improve accuracy of cytological and even histopathological diagnosis. To our knowledge, this novel technique tends to be employed without concrete knowledge of molecular changes in cells. Therefore, identification of Raman spectral markers for objective diagnosis is necessary for universal adoption of RS. As a model study, we investigated human mammary epithelial cells (HMEpC) and breast cancer cells (MCF-7) by RS and employed various multivariate analyses (MA) including principal components analysis (PCA), linear discriminant analysis (LDA), and support vector machine (SVM) to estimate diagnostic accuracy. Furthermore, to elucidate the underlying molecular changes in cancer cells, we utilized multivariate curve resolution analysis-alternating least squares (MCR-ALS) with non-negative constraints to extract physically meaningful spectra from complex cellular data. Unsupervised PCA and supervised MA, such as LDA and SVM, classified HMEpC and MCF-7 fairly well with high accuracy but without revealing molecular basis. Employing MCR-ALS analysis we identified five pure biomolecular spectra comprising DNA, proteins and three independent unsaturated lipid components. Relative abundance of lipid 1 seems to be strictly regulated between the two groups of cells and could be the basis for excellent discrimination by chemometrics-assisted RS. It was unambiguously assigned to linoleate rich glyceride and therefore serves as a Raman spectral marker for reliable diagnosis. This study successfully identified Raman spectral markers and demonstrated the potential of RS to become an excellent cytodiagnostic tool that can both accurately and objectively discriminates breast cancer from normal cells.

Entities:  

Keywords:  MCR-ALS; PUFA; Raman spectroscopy; breast cancer; cancer diagnosis; chemometrics; cpectral marker; cytodiagnosis; linoleic acid; lipid metabolism

Mesh:

Substances:

Year:  2021        PMID: 33466869      PMCID: PMC7830327          DOI: 10.3390/ijms22020800

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  34 in total

1.  Identifying microcalcifications in benign and malignant breast lesions by probing differences in their chemical composition using Raman spectroscopy.

Authors:  Abigail S Haka; Karen E Shafer-Peltier; Maryann Fitzmaurice; Joseph Crowe; Ramachandra R Dasari; Michael S Feld
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

Review 2.  Prostaglandins and cancer.

Authors:  D Wang; R N Dubois
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

3.  Discrimination of normal, benign, and malignant breast tissues by Raman spectroscopy.

Authors:  M V P Chowdary; K Kalyan Kumar; Jacob Kurien; Stanley Mathew; C Murali Krishna
Journal:  Biopolymers       Date:  2006-12-05       Impact factor: 2.505

Review 4.  Biological and Medical Applications of Multivariate Curve Resolution Assisted Raman Spectroscopy.

Authors:  Hemanth Noothalapati; Keita Iwasaki; Tatsuyuki Yamamoto
Journal:  Anal Sci       Date:  2017       Impact factor: 2.081

5.  Studying anti-oxidative properties of inclusion complexes of α-lipoic acid with γ-cyclodextrin in single living fission yeast by confocal Raman microspectroscopy.

Authors:  Hemanth Noothalapati; Ryo Ikarashi; Keita Iwasaki; Tatsuro Nishida; Tomohiro Kaino; Keisuke Yoshikiyo; Keiji Terao; Daisuke Nakata; Naoko Ikuta; Masahiro Ando; Hiro-O Hamaguchi; Makoto Kawamukai; Tatsuyuki Yamamoto
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2018-02-06       Impact factor: 4.098

6.  Raman spectroscopy of normal and diseased human breast tissues.

Authors:  C J Frank; R L McCreery; D C Redd
Journal:  Anal Chem       Date:  1995-03-01       Impact factor: 6.986

7.  Raman Spectroscopic Analysis Reveals Abnormal Fatty Acid Composition in Tumor Micro- and Macroenvironments in Human Breast and Rat Mammary Cancer.

Authors:  Sixian You; Haohua Tu; Youbo Zhao; Yuan Liu; Eric J Chaney; Marina Marjanovic; Stephen A Boppart
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

Review 8.  Lipid metabolism reprogramming and its potential targets in cancer.

Authors:  Chunming Cheng; Feng Geng; Xiang Cheng; Deliang Guo
Journal:  Cancer Commun (Lond)       Date:  2018-05-21

9.  Fibril formation and therapeutic targeting of amyloid-like structures in a yeast model of adenine accumulation.

Authors:  Dana Laor; Dorin Sade; Shira Shaham-Niv; Dor Zaguri; Myra Gartner; Vasantha Basavalingappa; Avi Raveh; Edward Pichinuk; Hamutal Engel; Keita Iwasaki; Tatsuyuki Yamamoto; Hemanth Noothalapati; Ehud Gazit
Journal:  Nat Commun       Date:  2019-01-08       Impact factor: 14.919

Review 10.  Emerging role of lipid metabolism alterations in Cancer stem cells.

Authors:  Mei Yi; Junjun Li; Shengnan Chen; Jing Cai; Yuanyuan Ban; Qian Peng; Ying Zhou; Zhaoyang Zeng; Shuping Peng; Xiaoling Li; Wei Xiong; Guiyuan Li; Bo Xiang
Journal:  J Exp Clin Cancer Res       Date:  2018-06-15
View more
  2 in total

1.  DNA Fingerprint Analysis of Raman Spectra Captures Global Genomic Alterations in Imatinib-Resistant Chronic Myeloid Leukemia: A Potential Single Assay for Screening Imatinib Resistance.

Authors:  Rahul Mojidra; Arti Hole; Keita Iwasaki; Hemanth Noothalapati; Tatsuyuki Yamamoto; Murali Krishna C; Rukmini Govekar
Journal:  Cells       Date:  2021-09-22       Impact factor: 6.600

2.  Who's Who? Discrimination of Human Breast Cancer Cell Lines by Raman and FTIR Microspectroscopy.

Authors:  Inês P Santos; Clara B Martins; Luís A E Batista de Carvalho; Maria P M Marques; Ana L M Batista de Carvalho
Journal:  Cancers (Basel)       Date:  2022-01-17       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.